Chemical Entities of Biological Interest
217828 terms(s) returned
| Term Type: Class | Record: 1 to 50 of 217828 Records | Page: 1 of 4357, First Previous Next Last | Show Records Per Page |
- ( -)-1-hydroxybybetaochlamic acid
- ( Z)-6-benzylidene-3-hydroxymethyl-1,4-dimethyl-3-methylsulfanylpiperazine-2,5-dione
- ((13)C)carbon dioxide
- ((13)C)urea
- ((13)C5,(15)N)-valine
- ((18)O)water
- ((1aR,2S,2aR,7aR)-1a,2a,6,6-tetramethyl-7-oxodecahydronaphtho[2,3-b]oxiren-2-yl)methyl palmitate
- ((2,2-Dimethyl-3-vinyl-2H-chromen-7-yl)oxy)triisopropylsilane
- ((2-bromo-4-methylphenyl){6-[(4-{[(2R)-3-(dimethylamino)-2-hydroxypropyl]oxy}phenyl)amino]pyrimidin-4-yl}amino)acetonitrile
- ((2-bromo-4-methylphenyl){6-[(4-{[(2S)-3-(dimethylamino)-2-hydroxypropyl]oxy}phenyl)amino]pyrimidin-4-yl}amino)acetonitrile
- ((2-bromo-4-methylphenyl){6-[(4-{[3-(dimethylamino)-2-hydroxypropyl]oxy}phenyl)amino]pyrimidin-4-yl}amino)acetonitrile
- ((201)Tl)thallium monochloride
- ((2S,3aS,4R,6S)-4-(hydroxymethyl)-6-(4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)tetrahydrofuro[3,4-d][1,3]dioxol-2-yl)methylphosphonic acid
- ((4R)-4-((3R,5R,9S,10S,12R,13R,14S,17R)-3,12-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycine
- ((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)-L-aspartic acid
- ((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycylglycine
- ((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)tyrosine
- ((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)valine
- ((4R)-4-((3R,5S,7R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2,2-dimethylpentanoyl)glycine
- ((4R)-4-((3R,5S,7R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)-D-phenylalanine
- ((4R)-4-((3R,5S,7R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)-L-phenylalanine
- ((6Z)-Adda3)Nodularin
- ((Imino(methoxy)methyl)amino)(diphenoxy)phosphine oxide
- ((R)-3-Hydroxybutanoyl)(n-2)
- ((R)-4-((3R,5R,6S,7R,8S,9S,10R,13R,14S,17R)-3,6,7-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoyl)glycine
- ()-3-Hydroxynonanoic acid
- ()-Conen
- (+)-(1(10)E,4E,6S,7R)-germacradien-6-ol
- (+)-(10E,15R)-10,11-dehydrocurvularin
- (+)-(10E,15R)-12-hydroxy-10,11-dehydrocurvularin
- (+)-(10E,15R)-13-hydroxy-10,11-dehydrocurvularin
- (+)-(10R)-7-hydroxy-3-(2-hydroxypropyl)-5,6-dimethylisochromen-1-one
- (+)-(11R,2'S)-erythro-mefloquine
- (+)-(11S,15R)-11-Hydroxycurvularin
- (+)-(12E,2S,3S,4R,5R,6R,9S,11S,15R)-3-benzoyloxy-5,6-epoxylathyr-12-en-15-ol-14-one
- (+)-(12E,2S,3S,4R,5R,6R,9S,11S,15R)-3-cinnamoyloxy-5,6-epoxylathyr-12-en-15-ol-14-one
- (+)-(12E,2S,3S,4R,5R,9S,11S,15R)-15-cinnamoyloxy-lathyra-6(17),12-diene-3,5-diol-14-one
- (+)-(17R)-apralactone A
- (+)-(1R)-1,12-dihydroxy-20-norabieta-5(10),8,11,13-tetraene
- (+)-(1R)-1-[4-(4-fluorophenyl)-2,6-diisopropyl-5-propylpyridin-3-yl]ethanol
- (+)-(1R,3R,3′R)-1,4-dimethoxy-3-(3′-hydroxy-3′-methyl-1′-tetralone)-1(3H)-isobenzofuran
- (+)-(1R,3R,6S,7S,11R)-3,12-dihydroxy-alpha-muurolene
- (+)-(1R,3R,6S,7S,11S)-3,12-dihydroxy-alpha-muurolene
- (+)-(1R,3R,6S,7S,8R,11S)-3,8,12-trihydroxy-alpha-muurolene
- (+)-(1R,5R,6R,7R,10R)-cadinan-4(11)-ene-1,5,12-triol
- (+)-(1R,5R,6R,7S,10R)-cadinan-3-ene-1,5-diol
- (+)-(1R,5S,6R,7S,10R)-cadinan-4(11)-ene-1,5-diol
- (+)-(1R,6S,7S)-tremul-2-ene-12(11)-lactone
- (+)-(1S,2S)-norcoronamic acid
- (+)-(2E,4E)-5-((S)-2,2-dimethyl-6-methylenecyclohexyl)-3-methylpenta-2,4-dienoic acid
